Analyzing dietary patterns and risk of AMD in a Maryland-based population.
Researchers at Johns Hopkins University in Baltimore, Maryland have identified a negative correlation with fish and shellfish consumption and incidence of age-related macular degeneration (AMD) in a Maryland population of over 2500 people. The results are published in the December issue of Ophthalmology.
Utilizing food frequency questionnaires, the team of academic researchers assessed weekly fish and shellfish consumption in 2520 residents of Salisbury, Maryland, age 65 to 84 years old.
Fundus photographs were then taken of subject eyes to determine the presence of drusens (yellow spots in the retina) and other signs of AMD.
Results of the study showed that subjects with advanced AMD were far less likely to consume fish or shellfish high in omega-3s. Another find from the study was a lack of relationship between AMD and consumption of crabs and oysters combined-both of which are high in zinc.
These findings appear to support evidence of omega-3 intake as being a benefit for eye health. To read the study abstract, click here.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.